Drug Profile
AZ 4374
Alternative Names: AZ4374Latest Information Update: 28 Nov 2021
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class
- Mechanism of Action Adenosine triphosphatase inhibitors; Bromodomain and extraterminal domain protein inhibitors; Growth inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Breast cancer